Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines
This study has been completed.
Sponsored by: Montefiore Medical Center
Information provided by: Montefiore Medical Center
ClinicalTrials.gov Identifier: NCT00122278
  Purpose

Migraines are a specific type of headache that frequently recur and are very painful. Although there are many medications that are effective against migraines, none of these medications cure 100% of migraines. Another problem with migraines is that although many times they get better after intravenous (IV) treatment in the emergency room (ER), about 1/3 of the time migraines recur the next day. The purpose of this research project is to see if adding a medication called dexamethasone to standard ER therapy will help patients get better quicker and stay pain-free more often than if they receive placebo.


Condition Intervention Phase
Migraine
Drug: dexamethasone 10mg IV
Phase III

Genetics Home Reference related topics: familial hemiplegic migraine
MedlinePlus related topics: Headache Migraine
Drug Information available for: Dexamethasone Dexamethasone acetate Dexamethasone Sodium Phosphate Doxiproct plus Corticosteroids
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Parenteral Corticosteroids as Adjuvant Therapy for Migraine Headaches

Further study details as provided by Montefiore Medical Center:

Primary Outcome Measures:
  • Persistent headache pain free at 24 hours [ Time Frame: 24 hours ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Pain and disability scores at 2 and 24 hours [ Time Frame: 24 hours ] [ Designated as safety issue: No ]

Enrollment: 205
Study Start Date: July 2005
Study Completion Date: August 2006
Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: dexamethasone 10mg IV
    corticosteroid
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Migraine with or without aura; probable migraine without aura

Exclusion Criteria:

  • Secondary headache
  • Allergy, contraindication or intolerance to study medication
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00122278

Locations
United States, New York
Jacobi Medical Center
Bronx, New York, United States, 10461
Columbia University Medical Center
Manhattan, New York, United States
St. Lukes Hospital
New York, New York, United States
Sponsors and Collaborators
Montefiore Medical Center
Investigators
Principal Investigator: Benjamin W. Friedman, MD, MS Albert Einstein College of Medicine of Yeshiva University
  More Information

Responsible Party: Albert Einstein College of Medicine ( Benjamin Friedman )
Study ID Numbers: MMC: 05-02-032S or CCI: 05-030
Study First Received: July 20, 2005
Last Updated: February 15, 2008
ClinicalTrials.gov Identifier: NCT00122278  
Health Authority: United States: Institutional Review Board

Keywords provided by Montefiore Medical Center:
migraine, emergency department, dexamethasone
Migraine with or without aura or probable migraine without aura as defined by ICHD, 2nd edition

Study placed in the following topic categories:
Dexamethasone
Migraine Disorders
Headache
Central Nervous System Diseases
Emergencies
Headache Disorders, Primary
Brain Diseases
Dexamethasone acetate
Headache Disorders
Migraine without Aura

Additional relevant MeSH terms:
Anti-Inflammatory Agents
Antineoplastic Agents, Hormonal
Antineoplastic Agents
Nervous System Diseases
Physiological Effects of Drugs
Gastrointestinal Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Antiemetics
Glucocorticoids
Hormones
Pharmacologic Actions
Autonomic Agents
Therapeutic Uses
Peripheral Nervous System Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on January 16, 2009